Shanghai Serum Bio-Technology Co., Ltd. engages in research, development, production, operation, and sales of antitoxin and antivenom serum products for biotoxins and biosafety in China. It offers equine anti-tetanus immunoglobulin, antivenom, and anti-rabies serum products. The company also engaged in the collection and sale of animal immune plasma. The company was founded in 1999 and is based in Shanghai, China.
Frequently asked questions
What sector does Shanghai Serum Bio-Technology Co. Ltd. A (688163) operate in?
Shanghai Serum Bio-Technology Co. Ltd. A belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Shanghai Serum Bio-Technology Co. Ltd. A (688163) current stock price?
As of the latest data, Shanghai Serum Bio-Technology Co. Ltd. A stock price is CN¥37.55, with a previous close of CN¥38.27. Shanghai Serum Bio-Technology Co. Ltd. A lost -CN¥0.72 in the last trading session, representing a -1.88% loss.
What is Shanghai Serum Bio-Technology Co. Ltd. A (688163) current market capitalization?
Shanghai Serum Bio-Technology Co. Ltd. A market cap is approximately 4.06 billion.
What is Shanghai Serum Bio-Technology Co. Ltd. A (688163) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.51.
What is Shanghai Serum Bio-Technology Co. Ltd. A (688163) Price-to-Earnings (P/E) ratio?
Shanghai Serum Bio-Technology Co. Ltd. A current P/E ratio is 73.63.
Does Shanghai Serum Bio-Technology Co. Ltd. A (688163) pay dividends?
Yes. Shanghai Serum Bio-Technology Co. Ltd. A pays semiannual dividends with an annualized yield of 0.64% and an estimated annual payout of CN¥0.24 per share.
When is the next ex-dividend date for Shanghai Serum Bio-Technology Co. Ltd. A (688163)?
The next ex-dividend date is scheduled for September 15, 2026.
What is Shanghai Serum Bio-Technology Co. Ltd. A (688163) beta (volatility) score?
Shanghai Serum Bio-Technology Co. Ltd. A has a beta of 0.609, indicating lower volatility than the overall market.
